AAAAAA

   
Results: 1-22 |
Results: 22
STUDY OF THE IMMUNOGENICITY OF DIFFERENT RECOMBINANT MENGO VIRUSES EXPRESSING HIV-1 AND SIV EPITOPES
Authors: VANDERRYST E NAKASONE T HABEL A VENET A GOMARD E ALTMEYER R GIRARD M BORMAN AM
Citation: E. Vanderryst et al., STUDY OF THE IMMUNOGENICITY OF DIFFERENT RECOMBINANT MENGO VIRUSES EXPRESSING HIV-1 AND SIV EPITOPES, Research in virology, 149(1), 1998, pp. 5-20
ADJUVANT IS REQUIRED WHEN USING ENV LIPOPEPTIDE CONSTRUCT TO INDUCE HIV TYPE 1-SPECIFIC NEUTRALIZING ANTIBODY-RESPONSES IN MICE IN-VIVO
Authors: SAUZET JP MOOG C KRIVINE A MARTINON F BOSSUS M GRASMASSE H TARTAR A GUILLET JG GOMARD E
Citation: Jp. Sauzet et al., ADJUVANT IS REQUIRED WHEN USING ENV LIPOPEPTIDE CONSTRUCT TO INDUCE HIV TYPE 1-SPECIFIC NEUTRALIZING ANTIBODY-RESPONSES IN MICE IN-VIVO, AIDS research and human retroviruses, 14(10), 1998, pp. 901-909
CYTOTOXIC T-CELL RESPONSES TO HIV-1 REVERSE-TRANSCRIPTASE, INTEGRASE AND PROTEASE
Authors: HAAS G SAMRI A GOMARD E HOSMALIN A DUNTZE J BOULEY EM IHLENFELDT HG KATLAMA C AUTRAN E
Citation: G. Haas et al., CYTOTOXIC T-CELL RESPONSES TO HIV-1 REVERSE-TRANSCRIPTASE, INTEGRASE AND PROTEASE, AIDS, 12(12), 1998, pp. 1427-1436
CROSS-REACTIONS BETWEEN THE CYTOTOXIC T-LYMPHOCYTE RESPONSES OF HUMANIMMUNODEFICIENCY VIRUS-INFECTED AFRICAN AND EUROPEAN PATIENTS
Authors: DURALI D MORVAN J LETOURNEUR F SCHMITT D GUEGAN N DALOD M SARAGOSTI S SICARD D LEVY JP GOMARD E
Citation: D. Durali et al., CROSS-REACTIONS BETWEEN THE CYTOTOXIC T-LYMPHOCYTE RESPONSES OF HUMANIMMUNODEFICIENCY VIRUS-INFECTED AFRICAN AND EUROPEAN PATIENTS, Journal of virology, 72(5), 1998, pp. 3547-3553
EVOLUTION OF CYTOTOXIC T-LYMPHOCYTE RESPONSES TO HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 IN PATIENTS WITH SYMPTOMATIC PRIMARY INFECTION RECEIVING ANTIRETROVIRAL TRIPLE THERAPY
Authors: DALOD M HARZIC M PELLEGRIN I DUMON B HOEN B SERENI D DESCHEMIN JC LEVY JP VENET A GOMARD E
Citation: M. Dalod et al., EVOLUTION OF CYTOTOXIC T-LYMPHOCYTE RESPONSES TO HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 IN PATIENTS WITH SYMPTOMATIC PRIMARY INFECTION RECEIVING ANTIRETROVIRAL TRIPLE THERAPY, The Journal of infectious diseases, 178(1), 1998, pp. 61-69
A PLACEBO-CONTROLLED CLINICAL-PHASE-I TRIAL WITH COMBINED ANTI-HIV-1 AND ANTI-INTERFERON-ALPHA IMMUNIZATION
Authors: COULAUD JP GOUGEON ML GOMARD E DESCAMPS D LEBON P ABOULKER JP BIZZINI B ZAGURY D
Citation: Jp. Coulaud et al., A PLACEBO-CONTROLLED CLINICAL-PHASE-I TRIAL WITH COMBINED ANTI-HIV-1 AND ANTI-INTERFERON-ALPHA IMMUNIZATION, AIDS, 11(7), 1997, pp. 937-938
VACCINE THERAPY IN EARLY HIV-1 INFECTION USING A RECOMBINANT CANARYPOX VIRUS EXPRESSING GP160(MN) (ALVAC-HIV) - A DOUBLE-BLIND CONTROLLED RANDOMIZED STUDY OF SAFETY AND IMMUNOGENICITY
Authors: TUBIANA R GOMARD E FLEURY H GOUGEON ML MOUTHON B PICOLET H KATLAMA C
Citation: R. Tubiana et al., VACCINE THERAPY IN EARLY HIV-1 INFECTION USING A RECOMBINANT CANARYPOX VIRUS EXPRESSING GP160(MN) (ALVAC-HIV) - A DOUBLE-BLIND CONTROLLED RANDOMIZED STUDY OF SAFETY AND IMMUNOGENICITY, AIDS, 11(6), 1997, pp. 819-820
IN-VIVO LONGITUDINAL ANALYSIS OF A DOMINANT TCR REPERTOIRE SELECTED IN HUMAN RESPONSE TO INFLUENZA-VIRUS
Authors: PREVOSTBLONDEL A LENGAGNE R LETOURNEUR F PANNETIER C GOMARD E GUILLET JG
Citation: A. Prevostblondel et al., IN-VIVO LONGITUDINAL ANALYSIS OF A DOMINANT TCR REPERTOIRE SELECTED IN HUMAN RESPONSE TO INFLUENZA-VIRUS, Virology, 233(1), 1997, pp. 93-104
HUMAN PEPTIDE TRANSPORTER DEFICIENCY - IMPORTANCE OF HLA-B IN THE PRESENTATION OF TAP-INDEPENDENT EBV ANTIGENS
Authors: DELASALLE H HOUSSAINT E PEYRAT MA ARNOLD D SALAMERO J PINCZON D STEVANOVIC S BAUSINGER H FRICKER D GOMARD E BIDDISON W LEHNER P UYTDEHAAG F SASPORTES M DONATO L RAMMENSEE HG CAZENAVE JP HANAU D TONGIO MM BONNEVILLE M
Citation: H. Delasalle et al., HUMAN PEPTIDE TRANSPORTER DEFICIENCY - IMPORTANCE OF HLA-B IN THE PRESENTATION OF TAP-INDEPENDENT EBV ANTIGENS, The Journal of immunology, 158(10), 1997, pp. 4555-4563
INFLUENCE OF STRONG CD4 EPITOPE ON LONG-TERM VIRUS-SPECIFIC CYTOTOXICT-CELL RESPONSES INDUCED IN-VIVO WITH PEPTIDES
Authors: SAUZET JP GRASMASSE H GUILLET JG GOMARD E
Citation: Jp. Sauzet et al., INFLUENCE OF STRONG CD4 EPITOPE ON LONG-TERM VIRUS-SPECIFIC CYTOTOXICT-CELL RESPONSES INDUCED IN-VIVO WITH PEPTIDES, International immunology, 8(4), 1996, pp. 457-465
DELAYED VIRUS-SPECIFIC CD8(-LYMPHOCYTE ACTIVITY IN AN HIV-INFECTED INDIVIDUAL WITH HIGH CD4(+) CELL COUNTS - CORRELATIONS WITH VARIOUS PARAMETERS OF DISEASE PROGRESSION() CYTOTOXIC T)
Authors: DALOD M FIORENTINO S DELAMARE C ROUZIOUX C SICARD D GUILLET JG GOMARD E
Citation: M. Dalod et al., DELAYED VIRUS-SPECIFIC CD8(-LYMPHOCYTE ACTIVITY IN AN HIV-INFECTED INDIVIDUAL WITH HIGH CD4(+) CELL COUNTS - CORRELATIONS WITH VARIOUS PARAMETERS OF DISEASE PROGRESSION() CYTOTOXIC T), AIDS research and human retroviruses, 12(6), 1996, pp. 497-506
COMPARATIVE EFFICIENCY OF SIMPLE LIPOPEPTIDE CONSTRUCTS FOR IN-VIVO INDUCTION OF VIRUS-SPECIFIC CTL
Authors: DEPREZ B SAUZET JP BOUTILLON C MARTINON F TARTAR A SERGHERAERT C GUILLET JG GOMARD E GRASMASSE H
Citation: B. Deprez et al., COMPARATIVE EFFICIENCY OF SIMPLE LIPOPEPTIDE CONSTRUCTS FOR IN-VIVO INDUCTION OF VIRUS-SPECIFIC CTL, Vaccine, 14(5), 1996, pp. 375-382
PREDOMINANT INVOLVEMENT OF CD8(-) LYMPHOCYTES IN HUMAN IMMUNODEFICIENCY VIRUS-SPECIFIC CYTOTOXIC ACTIVITY()CD28()
Authors: FIORENTINO S DALOD M OLIVE D GUILLET JG GOMARD E
Citation: S. Fiorentino et al., PREDOMINANT INVOLVEMENT OF CD8(-) LYMPHOCYTES IN HUMAN IMMUNODEFICIENCY VIRUS-SPECIFIC CYTOTOXIC ACTIVITY()CD28(), Journal of virology, 70(3), 1996, pp. 2022-2026
DIFFERENT PATTERNS OF HIV-1-SPECIFIC CYTOTOXIC T-LYMPHOCYTE ACTIVITY AFTER PRIMARY INFECTION
Authors: LAMHAMEDICHERRADI S CULMANNPENCIOLELLI B GUY B LY TD GOUJARD C GUILLET JG GOMARD E
Citation: S. Lamhamedicherradi et al., DIFFERENT PATTERNS OF HIV-1-SPECIFIC CYTOTOXIC T-LYMPHOCYTE ACTIVITY AFTER PRIMARY INFECTION, AIDS, 9(5), 1995, pp. 421-426
LONG-LASTING ANTIVIRAL CYTOTOXIC T-LYMPHOCYTES INDUCED IN-VIVO WITH CHIMERIC-MULTIRESTRICTED LIPOPEPTIDES
Authors: SAUZET JP DEPREZ B MARTINON F GUILLET JG GRASMASSE H GOMARD E
Citation: Jp. Sauzet et al., LONG-LASTING ANTIVIRAL CYTOTOXIC T-LYMPHOCYTES INDUCED IN-VIVO WITH CHIMERIC-MULTIRESTRICTED LIPOPEPTIDES, Vaccine, 13(14), 1995, pp. 1339-1345
IDENTIFICATION OF MULTIRESTRICTED IMMUNODOMINANT REGIONS RECOGNIZED BY CYTOLYTIC T-LYMPHOCYTES IN THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 NEF PROTEIN (VOL 68, PG 7340, 1994)
Authors: CULMANNPENCIOLELLI B LAMHAMEDICHERRADI S COUILLIN I GUEGAN N LEVY JP GUILLET JG GOMARD E
Citation: B. Culmannpenciolelli et al., IDENTIFICATION OF MULTIRESTRICTED IMMUNODOMINANT REGIONS RECOGNIZED BY CYTOLYTIC T-LYMPHOCYTES IN THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 NEF PROTEIN (VOL 68, PG 7340, 1994), Journal of virology, 69(1), 1995, pp. 618-618
PIMELAUTIDE OR TRIMEXAUTIDE AS BUILT-IN ADJUVANTS ASSOCIATED WITH AN HIV-1-DERIVED PEPTIDE - SYNTHESIS AND IN-VIVO INDUCTION OF ANTIBODY AND VIRUS-SPECIFIC CYTOTOXIC T-LYMPHOCYTE-MEDIATED RESPONSE
Authors: DEPREZ B GRASMASSE H MARTINON F GOMARD E LEVY JP TARTAR A
Citation: B. Deprez et al., PIMELAUTIDE OR TRIMEXAUTIDE AS BUILT-IN ADJUVANTS ASSOCIATED WITH AN HIV-1-DERIVED PEPTIDE - SYNTHESIS AND IN-VIVO INDUCTION OF ANTIBODY AND VIRUS-SPECIFIC CYTOTOXIC T-LYMPHOCYTE-MEDIATED RESPONSE, Journal of medicinal chemistry, 38(3), 1995, pp. 459-465
HLA-DEPENDENT VARIATIONS IN HUMAN-IMMUNODEFICIENCY-VIRUS NEF PROTEIN ALTER PEPTIDE HLA BINDING
Authors: COUILLIN I CONNAN F CULMANNPENCIOLELLI B GOMARD E GUILLET JG CHOPPIN J
Citation: I. Couillin et al., HLA-DEPENDENT VARIATIONS IN HUMAN-IMMUNODEFICIENCY-VIRUS NEF PROTEIN ALTER PEPTIDE HLA BINDING, European Journal of Immunology, 25(3), 1995, pp. 728-732
IDENTIFICATION OF MULTIRESTRICTED IMMUNODOMINANT REGIONS RECOGNIZED BY CYTOLYTIC T-LYMPHOCYTES IN THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 NEF PROTEIN
Authors: CULMANNPENCIOLELLI B LAMHAMEDICHERRADI S COUILLIN I GUEGAN N LEVY JP GUILLET JG GOMARD E
Citation: B. Culmannpenciolelli et al., IDENTIFICATION OF MULTIRESTRICTED IMMUNODOMINANT REGIONS RECOGNIZED BY CYTOLYTIC T-LYMPHOCYTES IN THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 NEF PROTEIN, Journal of virology, 68(11), 1994, pp. 7336-7343
IMPAIRED CYTOTOXIC T-LYMPHOCYTE RECOGNITION DUE TO GENETIC VARIATIONSIN THE MAIN IMMUNOGENIC REGION OF THE HUMAN-IMMUNODEFICIENCY-VIRUS-1 NEF PROTEIN
Authors: COUILLIN I CULMANNPENCIOLELLI B GOMARD E CHOPPIN J LEVY JP GUILLET JG SARAGOSTI S
Citation: I. Couillin et al., IMPAIRED CYTOTOXIC T-LYMPHOCYTE RECOGNITION DUE TO GENETIC VARIATIONSIN THE MAIN IMMUNOGENIC REGION OF THE HUMAN-IMMUNODEFICIENCY-VIRUS-1 NEF PROTEIN, The Journal of experimental medicine, 180(3), 1994, pp. 1129-1134
CYTOTOXIC T-LYMPHOCYTES IN HIV SIV INFECTION - A PARTICULAR STUDY OF THE NEF PROTEIN
Authors: VENET A BOURGAULT I CULMANNPENCIOLELLI B LAMHAMEDI S MARTINON F GOMARD E COUILLIN I SARAGOSTI S GUILLET JG LEVY JP
Citation: A. Venet et al., CYTOTOXIC T-LYMPHOCYTES IN HIV SIV INFECTION - A PARTICULAR STUDY OF THE NEF PROTEIN, AIDS research and human retroviruses, 9, 1993, pp. 190000041-190000041
INDUCTION OF VIRUS-SPECIFIC CYTOTOXIC T-LYMPHOCYTES IN-VIVO BY LIPOSOME-ENTRAPPED MESSENGER-RNA
Authors: MARTINON F KRISHNAN S LENZEN G MAGNE R GOMARD E GUILLET JG LEVY JP MEULIEN P
Citation: F. Martinon et al., INDUCTION OF VIRUS-SPECIFIC CYTOTOXIC T-LYMPHOCYTES IN-VIVO BY LIPOSOME-ENTRAPPED MESSENGER-RNA, European Journal of Immunology, 23(7), 1993, pp. 1719-1722
Risultati: 1-22 |